WO2001068565A3 - Chemoselective ligation by use of a phosphine - Google Patents

Chemoselective ligation by use of a phosphine Download PDF

Info

Publication number
WO2001068565A3
WO2001068565A3 PCT/US2001/008546 US0108546W WO0168565A3 WO 2001068565 A3 WO2001068565 A3 WO 2001068565A3 US 0108546 W US0108546 W US 0108546W WO 0168565 A3 WO0168565 A3 WO 0168565A3
Authority
WO
WIPO (PCT)
Prior art keywords
phosphine
final product
amide bond
engineered
chemoselective ligation
Prior art date
Application number
PCT/US2001/008546
Other languages
French (fr)
Other versions
WO2001068565A2 (en
Inventor
Carolyn Bertozzi
Eliana Saxon
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Priority to EP01957599A priority Critical patent/EP1263771B1/en
Priority to DE60120650T priority patent/DE60120650T2/en
Priority to AU2001281463A priority patent/AU2001281463A1/en
Publication of WO2001068565A2 publication Critical patent/WO2001068565A2/en
Publication of WO2001068565A3 publication Critical patent/WO2001068565A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5022—Aromatic phosphines (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/023—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution using racemisation inhibiting agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, The invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety, or which can be engineered to comprise a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine byproduct and producing a native amide bond in the final product. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).
PCT/US2001/008546 2000-03-16 2001-03-16 Chemoselective ligation by use of a phosphine WO2001068565A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01957599A EP1263771B1 (en) 2000-03-16 2001-03-16 Chemoselective ligation by use of a phosphine
DE60120650T DE60120650T2 (en) 2000-03-16 2001-03-16 CHEMOSELECTIVE ANNOUNCEMENT BY USING A PHOSPHINE
AU2001281463A AU2001281463A1 (en) 2000-03-16 2001-03-16 Chemoselective ligation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18983700P 2000-03-16 2000-03-16
US60/189,837 2000-03-16

Publications (2)

Publication Number Publication Date
WO2001068565A2 WO2001068565A2 (en) 2001-09-20
WO2001068565A3 true WO2001068565A3 (en) 2002-05-23

Family

ID=22698968

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/008546 WO2001068565A2 (en) 2000-03-16 2001-03-16 Chemoselective ligation by use of a phosphine

Country Status (6)

Country Link
US (7) US6570040B2 (en)
EP (1) EP1263771B1 (en)
AT (1) ATE329925T1 (en)
AU (1) AU2001281463A1 (en)
DE (1) DE60120650T2 (en)
WO (1) WO2001068565A2 (en)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001281463A1 (en) * 2000-03-16 2001-09-24 The Regents Of The University Of California Chemoselective ligation
US7256259B2 (en) 2000-05-12 2007-08-14 Wisconsin Alumni Research Foundation Methods for ligation of molecules to surfaces
AU6153001A (en) 2000-05-12 2001-11-26 Wisconsin Alumni Res Found Ligation method and reagents to form an amide bond
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) * 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7795210B2 (en) * 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
ATE361673T1 (en) 2002-03-28 2007-06-15 Unilever Nv ICE CREAM
US6974884B2 (en) 2002-06-07 2005-12-13 Wisconsin Alumni Research Foundation Chemical synthesis of reagents for peptide coupling
MXPA04012496A (en) * 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Pegylated factor vii glycoforms.
US20050233473A1 (en) * 2002-08-16 2005-10-20 Zyomyx, Inc. Methods and reagents for surface functionalization
BRPI0408358A (en) * 2003-03-14 2006-03-21 Neose Technologies Inc branched water-soluble polymers and their conjugates
WO2004087865A2 (en) * 2003-03-31 2004-10-14 The Regents Of The University Of California The preparation and application of ligand-biopolymer conjugates
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
MXPA05010773A (en) 2003-04-09 2005-12-12 Neose Technologies Inc Glycopegylation methods and proteins/peptides produced by the methods.
BRPI0410164A (en) * 2003-05-09 2006-05-16 Neose Technologies Inc compositions and methods for preparing human growth hormone glycosylation mutants
WO2005012484A2 (en) * 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US7534902B2 (en) * 2003-11-14 2009-05-19 Wisconsin Alumni Research Foundation Fluorescence assays with improved sensitivity
US7070941B2 (en) * 2003-11-17 2006-07-04 Board Of Regents, The University Of Texas System Methods and compositions for tagging via azido substrates
US8633157B2 (en) * 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
EP1694347B1 (en) * 2003-11-24 2013-11-20 BioGeneriX AG Glycopegylated erythropoietin
US7842661B2 (en) * 2003-11-24 2010-11-30 Novo Nordisk A/S Glycopegylated erythropoietin formulations
US20080305992A1 (en) * 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20070254836A1 (en) * 2003-12-03 2007-11-01 Defrees Shawn Glycopegylated Granulocyte Colony Stimulating Factor
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
CN101072789B (en) * 2004-01-08 2013-05-15 生物种属学股份公司 O-linked glycosylation of peptides
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
US20090292110A1 (en) * 2004-07-23 2009-11-26 Defrees Shawn Enzymatic modification of glycopeptides
WO2006021553A1 (en) * 2004-08-23 2006-03-02 Covalys Biosciences Ag Method for protein purification and labeling based on a chemoselective reaction
WO2006031811A2 (en) * 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
AU2005289404A1 (en) 2004-09-28 2006-04-06 Baylor University Spatially-defined modification of fresh tissue using covalent chemistry
CN101438252A (en) * 2004-10-07 2009-05-20 爱莫里大学 Multifunctional nanoparticle conjugates and their use
JP2008515876A (en) * 2004-10-07 2008-05-15 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Use of Staudinger ligation in imaging and therapy end kits for imaging and therapy
JP5948627B2 (en) 2004-10-29 2016-07-20 レイショファーム ゲーエムベーハー Fibroblast growth factor (FGF) remodeling and carbohydrate pegylation
EP2290369B1 (en) 2004-12-22 2013-08-14 California Institute Of Technology Methods for proteomic profiling using non-natural amino acids
WO2006074279A1 (en) * 2005-01-06 2006-07-13 Neose Technologies, Inc. Glycoconjugation using saccharyl fragments
EP1858543B1 (en) * 2005-01-10 2013-11-27 BioGeneriX AG Glycopegylated granulocyte colony stimulating factor
WO2006079364A1 (en) * 2005-01-31 2006-08-03 Stichting Voor De Technische Wetenschappen Specific and mild peptide or amide bond cleavage
GB0507123D0 (en) * 2005-04-08 2005-05-11 Isis Innovation Method
EP2386571B1 (en) 2005-04-08 2016-06-01 ratiopharm GmbH Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20110003744A1 (en) * 2005-05-25 2011-01-06 Novo Nordisk A/S Glycopegylated Erythropoietin Formulations
EP2975135A1 (en) 2005-05-25 2016-01-20 Novo Nordisk A/S Glycopegylated factor IX
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007030521A1 (en) * 2005-09-06 2007-03-15 Invitrogen Corporation Control of chemical modification
EP1986700A2 (en) * 2005-10-04 2008-11-05 Koninklijke Philips Electronics N.V. The staudinger reaction in imaging and therapy and kits for use in imaging and therapy
CN101511389A (en) * 2005-10-04 2009-08-19 皇家飞利浦电子股份有限公司 Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition
US20100247433A1 (en) * 2005-10-14 2010-09-30 California Institute Of Technology Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells
EP3591069A3 (en) * 2005-10-27 2020-03-04 The President and Fellows of Harvard College Methods and compositions for labeling nucleic acids
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
US7465544B2 (en) * 2006-01-11 2008-12-16 Wisconsin Alumni Research Foundation Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
US8114636B2 (en) * 2006-02-10 2012-02-14 Life Technologies Corporation Labeling and detection of nucleic acids
WO2008029281A2 (en) 2006-02-10 2008-03-13 Invitrogen Corporation Labeling and detection of post translationally modified proteins
CN101389675B (en) * 2006-02-21 2012-06-20 亨茨曼国际有限公司 Process for making a polyisocyanurate composite
US8816050B2 (en) * 2006-03-22 2014-08-26 The Scripps Research Institute Method of preparing glycopeptides
CN101410139A (en) * 2006-03-28 2009-04-15 皇家飞利浦电子股份有限公司 Use of the staudinger ligation in in vivo assembly of a biologically active compound
US9187532B2 (en) * 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
US7985783B2 (en) 2006-09-21 2011-07-26 The Regents Of The University Of California Aldehyde tags, uses thereof in site-specific protein modification
JP2010505874A (en) 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス Purification method for polypeptide conjugates
CN101600448B (en) * 2006-10-04 2015-11-25 诺和诺德公司 The sugar of the PEGization that glycerol connects and glycopeptide
FI20075030A0 (en) * 2007-01-18 2007-01-18 Suomen Punainen Risti Veripalv Method of modifying cells
KR20150064246A (en) * 2007-04-03 2015-06-10 바이오제너릭스 게엠베하 Methods of treatment using glycopegylated g―csf
WO2008151258A2 (en) * 2007-06-04 2008-12-11 Neose Technologies, Inc. O-linked glycosylation using n-acetylglucosaminyl transferases
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
US7968811B2 (en) * 2007-06-29 2011-06-28 Harley-Davidson Motor Company Group, Inc. Integrated ignition and key switch
US8207112B2 (en) * 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
US20100286067A1 (en) * 2008-01-08 2010-11-11 Biogenerix Ag Glycoconjugation of polypeptides using oligosaccharyltransferases
WO2009108806A1 (en) 2008-02-27 2009-09-03 Novo Nordisk A/S Conjugated factor viii molecules
US8034396B2 (en) * 2008-04-01 2011-10-11 Tyco Healthcare Group Lp Bioadhesive composition formed using click chemistry
CN104263816B (en) 2008-05-16 2018-10-19 生命技术公司 Double label method for measuring cell Proliferation
WO2010057220A1 (en) * 2008-11-17 2010-05-20 Wisconsin Alumni Research Foundation Preparation of diazo and diazonium compounds
WO2010096394A2 (en) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
EP2398850B1 (en) 2009-02-21 2018-08-22 Sofradim Production Medical devices with an activated coating
US8968733B2 (en) * 2009-02-21 2015-03-03 Sofradim Production Functionalized surgical adhesives
US9523159B2 (en) 2009-02-21 2016-12-20 Covidien Lp Crosslinked fibers and method of making same using UV radiation
US8877170B2 (en) * 2009-02-21 2014-11-04 Sofradim Production Medical device with inflammatory response-reducing coating
AU2010215931A1 (en) 2009-02-21 2011-10-13 Covidien Lp Medical devices having activated surfaces
US8663689B2 (en) * 2009-02-21 2014-03-04 Sofradim Production Functionalized adhesive medical gel
CA2753217A1 (en) 2009-02-21 2010-08-26 Sofradim Production Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices
US8535477B2 (en) 2009-02-21 2013-09-17 Sofradim Production Medical devices incorporating functional adhesives
US8968818B2 (en) 2009-02-21 2015-03-03 Covidien Lp Medical devices having activated surfaces
US9375699B2 (en) 2009-02-21 2016-06-28 Sofradim Production Apparatus and method of reacting polymers by exposure to UV radiation to produce injectable medical devices
US8512728B2 (en) 2009-02-21 2013-08-20 Sofradim Production Method of forming a medical device on biological tissue
CA2753179A1 (en) 2009-02-21 2010-08-26 Sofradim Production Crosslinked fibers and method of making same by extrusion
AU2010215192B2 (en) 2009-02-21 2015-04-30 Sofradim Production Amphiphilic compounds and self-assembling compositions made therefrom
WO2010095052A2 (en) 2009-02-21 2010-08-26 Sofradim Production Compounds and medical devices activated with solvophobic linkers
DE102009012640A1 (en) 2009-03-09 2010-09-30 Freie Universität Berlin Phosphoamidate group modified compound and its use
WO2011045418A1 (en) * 2009-10-16 2011-04-21 Dsm Ip Assets B.V. Azido alkanoic acids and derivatives thereof in feed for reducing methane formation emanating from the digestive activities of ruminants
FR2952058B1 (en) 2009-10-29 2013-10-04 Centre Nat Rech Scient PROCESS FOR NATIVE LIGATION OF POLYPEPTIDES
WO2011117745A2 (en) 2010-03-25 2011-09-29 Sofradim Production Surgical fasteners and methods for sealing wounds
US8795331B2 (en) 2010-03-25 2014-08-05 Covidien Lp Medical devices incorporating functional adhesives
US9247931B2 (en) 2010-06-29 2016-02-02 Covidien Lp Microwave-powered reactor and method for in situ forming implants
EP2588153A2 (en) 2010-07-01 2013-05-08 Sofradim Production Medical device with predefined activated cellular integration
EP2598178B1 (en) 2010-07-27 2018-07-11 Sofradim Production Polymeric fibers having tissue reactive members
KR20140016262A (en) 2011-01-14 2014-02-07 레드우드 바이오사이언스 인코포레이티드 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
FR2971509B1 (en) 2011-02-16 2013-02-22 Centre Nat Rech Scient PROCESS FOR PREPARING PEPTIDES BY ASSEMBLING MULTIPLE PEPTIDE FRAGMENTS
US20150072396A1 (en) 2011-03-04 2015-03-12 Life Technologies Corporation Compounds and Methods for Conjugation of Biomolecules
EP2688867B1 (en) 2011-03-25 2018-09-05 Life Technologies Corporation Heterobifunctional esters for use in labeling target molecules
US20140170653A1 (en) 2011-04-15 2014-06-19 Life Technologies Corporation Chemical ligation
US9556195B2 (en) 2011-09-12 2017-01-31 The Regents Of The University Of California Compositions and methods for quadricyclane modification of biomolecules
FR2981352B1 (en) 2011-10-17 2015-07-03 Centre Nat Rech Scient PROCESS FOR PROTEIN SYNTHESIS
FR2988392B1 (en) 2012-03-21 2014-04-11 Centre Nat Rech Scient NATIVE LIGATION METHOD
US20150246146A1 (en) 2012-10-25 2015-09-03 Life Technologies Corporation Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins
WO2014074218A1 (en) 2012-11-12 2014-05-15 Redwood Bioscience, Inc. Compounds and methods for producing a conjugate
US9775928B2 (en) 2013-06-18 2017-10-03 Covidien Lp Adhesive barbed filament
JP6745218B2 (en) 2013-11-27 2020-08-26 レッドウッド バイオサイエンス， インコーポレイテッド Methods for producing hydrazinyl-pyrrolo compounds and conjugates
DE102013113156A1 (en) * 2013-11-28 2015-05-28 Freie Universität Berlin A compound and method for selectively radiolabeling polypeptides by solid phase synthesis
US9410958B2 (en) 2014-03-25 2016-08-09 The Regents Of The University Of California Alkyne-activated fluorogenic azide compounds and methods of use thereof
US20180215783A1 (en) * 2015-08-13 2018-08-02 The Regents Of The University Of California Bioorthogonal reaction of an amine n-oxide and a boron agent
US10195283B2 (en) 2016-03-18 2019-02-05 R.P. Scherer Technologies, Llc Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate
US11208632B2 (en) 2016-04-26 2021-12-28 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same
WO2017218891A1 (en) 2016-06-17 2017-12-21 Life Technologies Corporation Site-specific crosslinking of antibodies
US10814036B2 (en) 2016-11-07 2020-10-27 Baylor University Drug-eluting live tissue for transplantation
EP3571223B1 (en) 2017-01-18 2024-09-18 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
US20220042078A1 (en) 2019-04-29 2022-02-10 Illumina, Inc. Identification and analysis of microbial samples by rapid incubation and nucleic acid enrichment
KR20240085798A (en) 2020-04-03 2024-06-17 비스테라, 인크. Antibody molecule-drug conjugates and uses thereof
WO2022251357A1 (en) 2021-05-27 2022-12-01 R.P. Scherer Technologies, Llc Methods of controlling cleavage of formylglycine-containing polypeptides
EP4108669A1 (en) * 2021-06-24 2022-12-28 Institute Of Organic Chemistry And Biochemistry As CR, V.V.I. Carbohydrate derivatives and kits for cell surface labeling
US11879010B2 (en) 2021-09-30 2024-01-23 The Charlotte Mecklenburg Hospital Authority Methods and compositions for pretargeted immunotherapy
CN117736135B (en) * 2024-02-19 2024-05-07 西北农林科技大学深圳研究院 Method for site-specific modification of proteins

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008657A2 (en) * 1988-03-09 1989-09-21 Cis Bio Internatonal Preparation of nitruro compounds usable as radio-pharmaceutical products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321366A (en) * 1978-05-12 1982-03-23 Research Corporation Process of preparing 2-azido-2-deoxyarabinofuranosyl halides
US4292437A (en) * 1979-06-27 1981-09-29 E. I. Du Pont De Nemours And Company Preparation of isobutyric acid and esters
DE4325816A1 (en) * 1993-07-31 1995-02-02 Hoechst Ag Secondary and tertiary phosphines and process for their preparation
US5874628A (en) * 1997-03-26 1999-02-23 Monsanto Company Method for preparation of tertiary phosphines via nickel-catalyzed cross coupling
AU2001281463A1 (en) * 2000-03-16 2001-09-24 The Regents Of The University Of California Chemoselective ligation
AU6153001A (en) 2000-05-12 2001-11-26 Wisconsin Alumni Res Found Ligation method and reagents to form an amide bond

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008657A2 (en) * 1988-03-09 1989-09-21 Cis Bio Internatonal Preparation of nitruro compounds usable as radio-pharmaceutical products

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
G MÄRKL & G YU JIN: "1,5-Diaza-3-phospha-cycloheptane-N,N'-Bis-[phosphinomethyl]-ethylendiamine mit optisch aktiven Seitenketten", TETRAHEDRON LETTERS., vol. 21, 1980, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM., NL, pages 3467 - 3470, XP002188900, ISSN: 0040-4039 *
J CHATT ET AL.: "Rhodium(I), rhodium(II), palladium(II) and platinum(II) complexes containing ligands of the type PRnQ3-n (n=0, 1 or 2; R=Mem Et, But or Ph; Q=CH2OCOMe or CH2OH)", JOURNAL OF THE CHEMICAL SOCIETY, DALTON TRANSACTIONS., no. 19, 1973, CHEMICAL SOCIETY. LETCHWORTH., GB, pages 2021 - 2028, XP002188899, ISSN: 1472-7773 *
O HERD ET AL: "Water-soluble phosphines VIII. Palladium-catalyzed P-C cross coupling reactions between primary or secondary phosphines and functional aryliodides - a novel synthetic route to water-soluble phosphines", JOURNAL OF ORGANOMETALLIC CHEMISTRY., vol. 522, 1996, ELSEVIER-SEQUOIA S.A. LAUSANNE., CH, pages 69 - 76, XP002188898, ISSN: 0022-328X *
SAXON, ELIANA (1) ET AL: "Development of a new chemoselective ligation reaction.", ABSTRACTS OF PAPERS AMERICAN CHEMICAL SOCIETY, (1999) VOL. 218, NO. 1-2, PP. CARB 23. MEETING INFO.: 218TH NATIONAL MEETING OF THE AMERICAN CHEMICAL SOCIETY, PARTS 1 AND 2 NEW ORLEANS, LOUISIANA, USA AUGUST 22-26, 1999 AMERICAN CHEMICAL SOCIETY., XP001059669 *
SAXON, ELIANA ET AL: "Cell surface engineering by a modified Staudinger reaction.", SCIENCE (WASHINGTON D C), (MARCH 17, 2000) VOL. 287, NO. 5460, PP. 2007-2010. PRINT., XP002188901 *

Also Published As

Publication number Publication date
DE60120650D1 (en) 2006-07-27
US20080214801A1 (en) 2008-09-04
US20020016003A1 (en) 2002-02-07
EP1263771A2 (en) 2002-12-11
US7923582B2 (en) 2011-04-12
US7667012B2 (en) 2010-02-23
AU2001281463A1 (en) 2001-09-24
ATE329925T1 (en) 2006-07-15
US6570040B2 (en) 2003-05-27
US20110236930A1 (en) 2011-09-29
US20060276658A1 (en) 2006-12-07
US7939626B2 (en) 2011-05-10
US20030199084A1 (en) 2003-10-23
US7122703B2 (en) 2006-10-17
US7838665B2 (en) 2010-11-23
US8076496B2 (en) 2011-12-13
US20050148032A1 (en) 2005-07-07
DE60120650T2 (en) 2007-05-31
WO2001068565A2 (en) 2001-09-20
US20070037964A1 (en) 2007-02-15
EP1263771B1 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
WO2001068565A3 (en) Chemoselective ligation by use of a phosphine
WO2006050262A3 (en) Compositions and methods for modification of biomolecules
WO2007107587A3 (en) Cholesterol lowering protein hydrolysates
WO2007022512A3 (en) Glycopegylated factor vii and factor viia
WO2007113224A3 (en) Conjugation process for pnag and a carrier protein
EP1225193A3 (en) Compositions for preparation of shapes of finally divided materials
US20090306036A1 (en) Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
WO2002043771A3 (en) Conjugates of glycosylated/galactosylated peptide
WO2007108013A3 (en) Novel bioconjugates as therapeutic agent and synthesis thereof
WO2005019251A8 (en) Novel fungal proteins and nucleic acids encoding same
WO2002080979A3 (en) Conjugate of hydroxyalkyl starch and an active agent
WO2003042101A3 (en) Ts-pq titano-silicate molecular sieves and methods for synthesis and use thereof
EP1095695A3 (en) Novel polyimide amic acid salts and polyimide membranes formed therefrom
WO2002038592A3 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2005092391A3 (en) Conjugates of hydroxyalkyl starch and a protein
WO2007068906A3 (en) Production of conjugates
WO2004083234A3 (en) Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
AU2002342597A1 (en) Process for preparing insulin compounds
WO2001087920A3 (en) Ligation method and reagents to form an amide bond
SG170022A1 (en) Method for production of peptide thioester compound
WO2006105201A3 (en) Conjugates comprised of fatty acid and hiv gp41-derived peptide
EP1452543A3 (en) RGD (ARG-GLY-ASP) coupled to (neuro)peptides
WO2006047628A3 (en) Amino or thiol linker building block for the synthesis of amino- or thiol-functionalized nucleic acids and methods of making and use thereof
FR2864534B1 (en) SYNTHESIS OF ACYLUREES AND COMPOSITION COMPRISING ACYLUREES
WO2003018523A1 (en) Process for producing optically active halopropanediol derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2001957599

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001957599

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 2001957599

Country of ref document: EP